Table 2.
Comparison of eyes according to the alterations in the final visual acuity.
|
Final BCVA
improvement ≥2 logMAR lines (n=18) |
Final BCVA improvement <2 logMAR lines (n=18) | p-value | |
|---|---|---|---|
| Age | 61.6 ± 9.9 | 62.5 ± 9.1 | 0.832 |
| Gender | |||
| Male (%) | 58.3 | 50.0 | 0.682 |
| Female (%) | 41.7 | 50.0 | |
| Time of DM (years) | 10.6 ± 3.3 | 12.6 ± 1.7 | 0.063 |
| HbA1c (%) | 7.39 ± 0.38 | 7.32 ± 0.42 | 0.690 |
| Baseline BCVA (logMAR) | 0.60 ± 0.31 | 0.49 ± 0.25 | 0.328 |
| Baseline CRT (µm) | 525.6 ± 167.9 | 463.8 ± 134.4 | 0.331 |
| Baseline total cyst area (µm2) | 10102.5 ± 3316.3 | 11178.5 ± 4271.8 | 0.498 |
| Baseline mean intracystic reflectance | 40.5 ± 6.2 | 49.1 ± 7.9 | 0.028* |
| Hyperreflective dots (number) | 13.6 ± 8.4 | 16.4 ± 9.3 | 0.443 |
| Presence of DRIL | |||
| Yes (%) | 16.7 | 66.7 | 0.011* |
| No (%) | 83.3 | 33.3 | |
| Presence of subretinal fluid | |||
| Yes (%) | 44.4 | 38.8 | 0.346 |
| No (%) | 55.6 | 61.2 | |
| Presence of cyst in outer retinal layer | |||
| Yes (%) | 83.3 | 41.7 | 0.015* |
| No (%) | 16.7 | 58.3 | |
| Presence of TPHM | |||
| Yes (%) | 27.8 | 50.0 | 0.145 |
| No (%) | 72.2 | 50.0 | |
| Presence of disrupted EZ | |||
| Yes (%) | 38.8 | 77.7 | 0.019 |
| No (%) | 61.2 | 22.3 | |
| Final CRT (µm) | 222.5 ± 107.2 | 319.1 ± 117.8 | 0.047* |
| Final total cyst area (µm2) | 910.2 ± 179.7 | 1890.8 ± 436.8 | 0.074 |
BCVA= best-corrected visual acuity; CRT, central retinal thickness; DM= diabetes mellitus; DRIL= disorganization of retinal inner layers; HbA1c= hemoglobin A1C; TPHM= taut posterior hyaloid membrane.